Immunomodulation and effect on cell processes relating to serotonin family receptors

Details for Australian Patent Application No. 2002305123 (hide)

Owner Philadelphia Health and Education Corporation

Inventors Davidson, Harold Carter; Tretiakova, Anna S.; Albert, Ross; Jameson, Bradford A.

Agent Pizzeys

Pub. Number AU-B-2002305123

PCT Number PCT/US02/09993

PCT Pub. Number WO2002/078643

Priority 60/345,295 25.10.01 US; 60/353,883 31.01.02 US; 60/280,296 30.03.01 US

Filing date 29 March 2002

Wipo publication date 15 October 2002

Acceptance publication date 5 October 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/345,295 25.10.01 US; 60/353,883 31.01.02 US; 60/280,296 30.03.01 US

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002305123

5 October 2006 Application Accepted

  Published as AU-B-2002305123

1 February 2007 Standard Patent Sealed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305124-MAGNESIUM CONVERSION COATING COMPOSITION AND METHOD OF USING SAME

2002305122-ISOLATED HUMAN ENZYME PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN ENZYME PROTEINS, AND USES THEREOF